Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents

NCT00663234 is registered in ClinicalTrials.gov with International Maternal Pediatric Adolescent AIDS Clinical Trials Group as lead sponsor.

NCT NCT00663234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00663234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents
Lead sponsor
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Phase
Phase 1/2
Overall status
Terminated
Start date
August 31, 2009
Completion date
December 31, 2014
Enrollment
28 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections, hyperlipidemia